Proprietary & Confidential—This material is proprietary to My Life Spark P.C. Unauthorized use, reproduction, or distribution is strictly prohibited.
Governance
Every clinical decision in the Life Spark protocol — surveillance cadence, deprescribing criteria, transition milestones, vaccine timing — is governed by a multidisciplinary board with a voting survivor and caregiver seat. This page describes the seats, the charter, and the operating cadence. Named members are published on the protocol changelog when each version is released.
Owns adherence of the adult protocol to NCCN Survivorship, ASCO survivorship guidelines, and disease-specific late-effect pathways.
Seat profile
Board-certified medical oncologist with a dedicated survivorship clinic and prior guideline-writing experience.
Owns pediatric and AYA transition, COG-LTFU 6.0 alignment, and the childhood-cancer late-effects surveillance schedule.
Seat profile
Pediatric hematologist/oncologist directing a long-term follow-up program with COG affiliation.
Owns anthracycline / HER2 / radiation cardiotoxicity surveillance, imaging cadence, and cardioprotective referral criteria.
Seat profile
Cardiologist with cardio-oncology fellowship or ACC Cardio-Oncology Section membership.
Owns thyroid, adrenal, gonadal, growth, and metabolic surveillance for pediatric-onset survivors carried into adulthood.
Seat profile
Endocrinologist practicing in a survivorship or late-effects clinic.
Owns the primary-care handoff, panel management, and quality-metric alignment (HEDIS, MIPS, value-based contracts).
Seat profile
Internal medicine or family medicine physician with population-health leadership experience.
Owns distress screening thresholds, cognitive late-effect pathways, and integrated behavioral-health referral standards.
Seat profile
Psycho-oncology or neuropsychology clinician with survivorship experience.
Owns care-plan handoff, nurse navigator scripts, and the between-visit surveillance workflow.
Seat profile
Oncology nurse navigator (ONN-CG) with survivorship program leadership.
Owns the deprescribing worksheet, long-term therapy interactions, and vaccine/immunosuppression pharmacology.
Seat profile
BCOP-certified oncology pharmacist embedded in survivorship or ambulatory care.
Owns access review, language access, cost-of-care transparency, and community-partner integration.
Seat profile
Public-health or community-medicine leader with cancer-equity portfolio.
Voting seats. Review every patient-facing artifact, plain-language reading level, and consent flow before release.
Seat profile
One adult-onset survivor, one childhood-cancer survivor or parent caregiver.
Quarterly
Full board review of protocol changes, safety signals, and outcomes dashboard.
Monthly
Working-group calls per specialty seat with the medical director.
Annually
Public protocol version release with a signed changelog and evidence table.
We recruit board members with published survivorship work and lived expertise. Survivor and caregiver seats are compensated and voting. If you fit a seat above, tell us which one.